Newswise — February 19, 2015 - Wolters Kluwer is pleased to announce today that it is the official publisher of the Cardiopulmonary Physical Therapy Journal, official journal of the Cardiovascular & Pulmonary Section of the American Physical Therapy Association (APTA) with the release of its March issue. The journal is part of Wolters Kluwer’s Lippincott Williams & Wilkins portfolio of nearly 300 medical, nursing and allied health titles. This is the sixth APTA section journal published by Wolters Kluwer.

Updated Journal for a New Era in Cardiopulmonary Physical RehabilitationPublished quarterly, the Cardiopulmonary Physical Therapy Journal presents original research, case reports, and reviews on the art and science of cardiovascular and pulmonary physical therapy. Clinical perspective pieces provide expert insights on theoretical, practical, or professional issues relevant to physical therapy for patients with cardiovascular and pulmonary conditions.

APTA Members and journal subscribers will see a fully redesigned journal on its upgraded website,, with access to the full contents of each issue online and on mobile devices. In addition to current content, registered users to the website can search the journal’s 25-year history, create article collections, alerts, share articles, and more.

A streamlined electronic manuscript submission, review, and tracking process is now accessible to authors and reviewers at

# # #

About Cardiopulmonary Physical Therapy JournalCardiopulmonary Physical Therapy Journal, the official publication of the Cardiovascular and Pulmonary Section, APTA, is a unique journal that highlights research in the areas of cardiovascular and pulmonary disease, health and wellness, and the role that physical therapists play in the management of primary, secondary and tertiary prevention. Topics range from physiological analysis to educational interventions, and authors from all over the world are represented. Our mission is to advance patient care, education and research in these areas.

About Wolters Kluwer HealthWolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth.